← back to database
Concentrated early-stage investor partnering with founders using technology and science to address acute American problems, including sovereign defense, advanced manufacturing, life sciences and healthcare, food production, and insurance.
Stage focus
Lead / follow
Check size
Ownership target
Specialization
Generalist / Specialist
Specialist
Latest fund size
$93M Fund I ($125M target)
Latest fund vintage
2020
Investing team
Colin GreensponCo-Founder
Falon DonohuePartner
Notable investments
Hallow, Rumble, AcreTrader, True Anomaly, Strive, Kriya Therapeutics